Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioProcess Algae is a biotechnology company that specializes in the design, construction, and operation of commercial-scale algae cultivation systems. The company utilizes its proprietary Grower Harvester™ bioreactor technology to convert co-products from industrial processes, such as carbon dioxide and waste heat, into high-value algal biomass. This biomass is processed into products for the animal feed, nutraceutical, and biofuel markets, with a specific focus on high-quality Omega-3 fatty acids like docosahexaenoic acid. Originally formed as a joint venture, the company's operations were centered in Shenandoah, Iowa, adjacent to ethanol production facilities to leverage available feedstock. Following its acquisition by Green Plains, the technology has been integrated into broader efforts to produce sustainable ingredients for global food and feed supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioProcess Algae.